CTHRC1 as a Novel Regulatory Target of Type I Collagen Synthesis via ATF4 in Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by excessive deposition of extracellular matrix, primarily type I collagen. This study investigates the role of Collagen triple helix repeat containing 1 (CTHRC1) in pulmonary fibrosis. Analysis of public databases and validation in mouse models revealed that CTHRC1 expression is significantly upregulated and strongly correlates with type I collagen. Single-cell RNA sequencing and immunofluorescence supported a close association between CTHRC1 and myofibroblasts in fibrotic lungs. In vitro, CTHRC1 knockdown in NIH3T3 fibroblasts attenuated TGF-β1-induced type I collagen production. Mechanistically, CTHRC1 silencing reduced phosphorylation of the TGF-β receptor I and its downstream effectors Smad2/3, accompanied by reduced protein expression of the transcription factor ATF4 and its target, the collagen synthesis enzyme PSAT1. These findings support a CTHRC1–TGF-β/Smad–ATF4/PSAT1 signaling model for type I collagen regulation, providing a basis for further investigation of CTHRC1 and the associated pathway as potential therapeutic targets in IPF.
Authors
- 赵育桢
- Juan Chen (ORCID: https://orcid.org/0000-0001-7515-5072)
- Chenhong Shi
- Rui Yan (ORCID: https://orcid.org/0009-0001-6579-7087)
- Ziyu Qiao
- Yuhan Di (ORCID: https://orcid.org/0009-0003-1617-2122)
- Yixuan Li (ORCID: https://orcid.org/0000-0002-8000-3417)
- Yiran Zhang
- Wen Zhang
- Ran Bi
- Yanan Sun
Institutions
- Chinese PLA General Hospital (CN)
- China Agricultural University (CN)
Publication Details
- Journal
- Molecules
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3390/molecules31224088
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China Association for Science and Technology
- Ministry of Education of the People's Republic of China